Browsing Tag
Interventional Oncology
5 posts
How the TIGeR-PaC sub-study could influence future thinking around chemotherapy tolerability and precision delivery
RenovoRx’s TIGeR-PaC sub-study highlights how targeted chemotherapy delivery could reshape pancreatic cancer treatment strategy. Read more.
From hearts to tumors: How pulsed electric field technology is making the leap into oncology
Galvanize’s PROPEL Registry highlights how pulsed electric field ablation, first used in arrhythmia care, is now emerging in oncology. Learn why adoption matters.
Galvanize Therapeutics enrolls first patient in PROPEL Registry for Aliya pulsed electric field ablation in soft tissue lesions
Galvanize enrolls first patient in PROPEL Registry for Aliya pulsed electric field ablation in soft tissue tumors. Find out what this means for oncology.
Sirtex Medical earns FDA nod for SIR-Spheres® Y-90 in treating unresectable liver cancer in U.S.
Sirtex Medical gains FDA approval for SIR-Spheres® Y-90 in treating unresectable hepatocellular carcinoma, expanding its U.S. radioembolization therapy scope.
Breakthrough study reveals Delcath Systems’ therapy doubles survival for uveal melanoma patients
Delcath Systems, Inc. (Nasdaq: DCTH), a pioneering company in interventional oncology, has announced promising results from a recent…